CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Nature communications 10 (1), 4016, 2019 | 257 | 2019 |
Temozolomide for immunomodulation in the treatment of glioblastoma A Karachi, F Dastmalchi, DA Mitchell, M Rahman Neuro-oncology 20 (12), 1566-1572, 2018 | 228 | 2018 |
Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang, W Zhang, ... Cancer research 80 (3), 499-509, 2020 | 86 | 2020 |
The IDH1 mutation-induced oncometabolite, 2-hydroxyglutarate, may affect DNA methylation and expression of PD-L1 in gliomas L Mu, Y Long, C Yang, L Jin, H Tao, H Ge, YE Chang, A Karachi, ... Frontiers in molecular neuroscience 11, 82, 2018 | 78 | 2018 |
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition A Karachi, C Yang, F Dastmalchi, EJ Sayour, J Huang, H Azari, Y Long, ... Neuro-oncology 21 (6), 730-741, 2019 | 75 | 2019 |
Personalized tumor RNA loaded lipid-nanoparticles prime the systemic and intratumoral milieu for response to cancer immunotherapy EJ Sayour, A Grippin, G De Leon, B Stover, M Rahman, A Karachi, ... Nano letters 18 (10), 6195-6206, 2018 | 65 | 2018 |
Ultrasound wave assisted removal of Ceftriaxone sodium in aqueous media with novel nano composite g-C3N4/MWCNT/Bi2WO6 based on CCD-RSM model X Shi, A Karachi, M Hosseini, MS Yazd, H Kamyab, M Ebrahimi, ... Ultrasonics sonochemistry 68, 104460, 2020 | 63 | 2020 |
The role of CMV in glioblastoma and implications for immunotherapeutic strategies M Rahman, F Dastmalchi, A Karachi, D Mitchell Oncoimmunology 8 (1), e1514921, 2019 | 58 | 2019 |
Adult immuno-oncology: using past failures to inform the future M Rahman, WG Sawyer, S Lindhorst, LP Deleyrolle, JK Harrison, ... Neuro-oncology 22 (9), 1249-1261, 2020 | 24 | 2020 |
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling F Dastmalchi, A Karachi, C Yang, H Azari, EJ Sayour, A Dechkovskaia, ... Journal for Immunotherapy of Cancer 7, 1-13, 2019 | 23 | 2019 |
Evaluation of immunomodulatory effects of mesenchymal stem cells soluble factors on miR-155 and miR-23b expression in mice dendritic cells A Karachi, M Fazeli, MH Karimi, B Geramizadeh, A Moravej, ... Immunological Investigations 44 (5), 427-437, 2015 | 20 | 2015 |
Metabolomics monitoring of treatment response to brain tumor immunotherapy F Dastmalchi, LP Deleyrolle, A Karachi, DA Mitchell, M Rahman Frontiers in Oncology 11, 691246, 2021 | 16 | 2021 |
Effect of timing and complement receptor antagonism on intragraft recruitment and protolerogenic effects of mesenchymal stromal cells in murine kidney transplantation F Casiraghi, M Todeschini, N Azzollini, P Cravedi, P Cassis, S Solini, ... Transplantation 103 (6), 1121-1130, 2019 | 16 | 2019 |
Clinical relevance of serum sialic acids evaluation and correlation with haptoglobin and serum amyloid A in diseased cattle. S Nazifi, M Ansari-Lari, MR Tabandeh, K Badiei, N Ghafari, I Karachi, ... Bulgarian Journal of Veterinary Medicine 13 (1), 2010 | 11 | 2010 |
Optimizing T cell-based therapy for glioblastoma A Karachi, F Dastmalchi, S Nazarian, J Huang, EJ Sayour, L Jin, C Yang, ... Frontiers in immunology 12, 705580, 2021 | 10 | 2021 |
CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat. Commun. 10, 4016 L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Molecular Therapy: Methods & Clinical Development, 2019 | 7 | 2019 |
Immunotherapy for treatment of cancer A Karachi Current Trends in Cancer Management, 2018 | 6 | 2018 |
Application of lysozyme and dextran conjugated lysozyme as natural antimicrobial agents in the treatment of experimental skin wound in mice A Karachi, H Rajaian, MM Aminlari, A Tabatabaee International Journal of Pharmaceutical Sciences and Research 4 (11), 4236, 2013 | 5 | 2013 |
Comparing standard performance and outcome measures in hospitalized pituitary tumor patients with secretory versus nonsecretory tumors AL Vlasak, DH Shin, PS Kubilis, SN Roper, A Karachi, BL Hoh, ... World Neurosurgery 135, e510-e519, 2020 | 4 | 2020 |
mRNA aggregates harness danger response for potent cancer immunotherapy H Mendez-Gomez, A DeVries, P Castillo, B Stover, S Qdaisat, ... medRxiv, 2023.03. 12.23287108, 2023 | 3 | 2023 |